Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - OTHER LIABILITIES
Other Liabilities EBS - Emergent BioSolutions Inc.
76.1 M
LAST VALUE
36.91%
2 YEAR CAGR
-5.98%
5 YEAR CAGR
15.00%
10 YEAR CAGR